The global defibrillator market size was valued at USD 15.18 billion in 2025 and is projected to grow from USD 16.21 billion in 2026 to USD 27.46 billion by 2034, registering a CAGR of 6.81% during the forecast period from 2026 to 2034. North America dominated the defibrillator market with a market share of 38.6% in 2025.
A defibrillator is a medical device that delivers a controlled electrical shock to the heart to help restore a normal heart rhythm during life-threatening cardiac conditions such as sudden cardiac arrest. Defibrillators are available in different types, including automated external defibrillators (AEDs), implantable cardioverter-defibrillators (ICDs), and manual devices. They are widely used in hospitals, emergency services, clinics, and public spaces to provide rapid cardiac intervention.
Download a Free Sample To learn more about this report,
Growing Adoption of Compact and Portable Automated External Defibrillators
The defibrillator market is increasingly moving toward compact, lightweight, and easy-to-use automated external defibrillators (AEDs) that can be deployed in homes, vehicles, sports facilities, workplaces, and other community settings. Manufacturers and emergency-care organizations are focusing on portability, simplified operation, and rapid accessibility to reduce the time between cardiac arrest and defibrillation. This trend is supporting the defibrillator market size as public-access and community-based emergency response programs expand.
In July 2026, St John Ambulance Australia launched the St John Pocket AED, a portable defibrillator weighing approximately 700 grams and designed to fit inside backpacks, glove boxes, first-aid kits, and other small spaces. The device aims to make clinically capable defibrillation available closer to people experiencing sudden cardiac arrest.
Increasing Integration of Smart Monitoring and Advanced Defibrillation Technologies
Another important trend is the integration of connectivity, remote monitoring, advanced diagnostics, and intelligent management features into defibrillators. These technologies can help healthcare providers monitor device readiness, track battery and electrode status, and improve emergency-response workflows. At the same time, manufacturers are developing next-generation monitor-defibrillators and wearable defibrillation systems to provide more personalized protection. This development is supporting defibrillator market growth as healthcare systems prioritize connected emergency-care technologies.
In February 2026, ZOLL Medical received MDR approval for its ZOLL Zenix Monitor/Defibrillator, expanding its portfolio of advanced emergency-care devices. The development reflects continued innovation in integrated monitoring and defibrillation technologies for professional healthcare settings.
Growing Need for Rapid Cardiac Emergency Response
Sudden cardiac arrest requires rapid intervention, and defibrillators remain an important part of emergency response because early defibrillation combined with CPR can improve the chance of survival. Hospitals, emergency medical services, airports, workplaces, schools, sports facilities, and other public locations are increasingly emphasizing access to automated external defibrillators (AEDs). The need for portable and easy-to-use devices is therefore strengthening defibrillator market demand, particularly as public-access programs and emergency preparedness initiatives expand. The FDA describes AEDs as portable life-saving devices designed to analyze cardiac rhythm and deliver a shock when appropriate.
In June 2026, the FDA approved a labeling supplement for Defibtech AED systems that added an optional maintenance function for continuously monitoring the readiness of DDU-2XXX series AEDs.
Strict Regulatory Requirements and Ongoing Maintenance Needs
Defibrillators are life-critical medical devices, requiring stringent regulatory oversight, quality controls, testing, maintenance, and reliable accessories such as batteries and electrode pads. Manufacturers must demonstrate safety and effectiveness before approval, while healthcare facilities and public-access operators need to ensure devices remain ready for emergency use. These requirements increase ownership and compliance costs and remain important in defibrillator market analysis. Product modifications can also require regulatory review, adding time and complexity to technology upgrades. The FDA continues to monitor AED manufacturing, design changes, performance reports, and post-market safety issues.
In May 2026, the FDA approved a Philips HeartStart FRx and FR3 labeling supplement covering a new adhesive material for electrode pads, illustrating the regulatory controls applied even to component and material changes.
Advancement of Connected and Wearable Defibrillation Technologies
Technological development is creating opportunities for defibrillators that provide improved monitoring, connectivity, automated diagnostics, and more personalized patient management. Wearable cardioverter-defibrillators can provide continuous protection for selected patients who may be at risk of life-threatening arrhythmias without immediately requiring an implanted device. These defibrillator market trends are encouraging manufacturers to improve usability, monitoring capabilities, battery performance, and remote management. Continued innovation in electrode technology and device software can also improve reliability and simplify maintenance, creating opportunities across hospitals, emergency services, and home-based patient care.
In July 2026, the FDA recorded a supplement for Kestra Medical Technologies' ASSURE Wearable Cardioverter Defibrillator System involving the relocation of manufacturing equipment to a new supplier facility, reflecting continued development and commercialization of wearable defibrillation technology.
Maintaining Device Reliability During Critical Emergency Use
Defibrillators must operate correctly when they are needed, sometimes after long periods of inactivity. Battery condition, electrode integrity, software performance, component reliability, environmental exposure, and maintenance practices can all affect readiness. Manufacturers therefore need robust quality systems and continuous monitoring throughout the device lifecycle. This remains a major consideration for the defibrillator market report, particularly as devices become more sophisticated and incorporate additional software and connected features. Maintaining reliability while introducing new technologies requires extensive testing, regulatory oversight, post-market surveillance, and effective maintenance procedures.
In August 2026, the FDA approved a minor software modification for the LIFEPAK 35 monitor/defibrillator, demonstrating the continued need for controlled software changes and regulatory oversight throughout the lifecycle of advanced defibrillation equipment.
Implantable Cardioverter Defibrillators (ICDs) Segment Dominated the Market with 61.7% Share in 2025
The implantable cardioverter defibrillators (ICDs) segment dominated the global defibrillator market with a 61.7% market share in 2025, valued at USD 9.37 billion. The segment's leadership is supported by the established role of ICDs in continuously monitoring cardiac rhythms and delivering corrective electrical therapy when life-threatening arrhythmias are detected. Growing awareness of sudden cardiac arrest risks and advances in device technology are supporting the use of ICDs among patients requiring long-term protection.
External defibrillators continue to play an important role in emergency cardiac care across hospitals, ambulances, public locations, and other healthcare environments. Improvements in portability, automated operation, ease of use, and connectivity are helping expand access to rapid defibrillation during cardiac emergencies.
Request Customizationto receive a tailored report.
Home Healthcare Segment is Projected to Register the Fastest Growth at a CAGR of 8.73%
The home healthcare segment is projected to register the fastest growth at a CAGR of 8.73% during the forecast period. Increasing interest in decentralized healthcare and remote patient management is supporting the use of cardiac monitoring and emergency-care technologies outside traditional hospital settings. Advances in compact device design and growing awareness of early intervention are also contributing to opportunities for defibrillator use in home-based care environments.
Hospitals, pre-hospital services, public access locations, alternate care facilities, and other healthcare settings continue to represent important areas of defibrillator demand. Expanding emergency response infrastructure and greater availability of automated external defibrillators are helping improve access to timely cardiac intervention in both clinical and community environments.
Speak to an Analystto discuss market opportunities.
The North American defibrillator market accounted for 38.6% of the global market, reaching USD 5.86 billion in 2025, and is projected to grow at a CAGR of 6.74% during the forecast period. The region's leading position is supported by the high prevalence of cardiovascular diseases, established emergency medical infrastructure, widespread availability of advanced cardiac care, and increasing adoption of automated external defibrillators across hospitals, public facilities, and other emergency response settings.
The United States represents a major market in North America. Strong healthcare infrastructure, increasing demand for emergency cardiac care, widespread adoption of AEDs, and continued technological advancements in defibrillation devices support market development.
Canada's established healthcare system, increasing focus on emergency cardiac response, and growing availability of defibrillation equipment across healthcare and public settings continue to support market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
The European defibrillator market accounted for 27.4% of the global market, reaching USD 4.16 billion in 2025, and is expected to register a CAGR of 6.58% during the forecast period. Rising cardiovascular disease burden, increasing investments in emergency medical infrastructure, growing awareness of sudden cardiac arrest response, and adoption of technologically advanced defibrillators continue to support regional growth.
Germany represents a major European market. Its advanced healthcare infrastructure, strong emergency medical services, and increasing adoption of modern cardiac care technologies continue to support defibrillator market development.
The United Kingdom's focus on emergency cardiac response, increasing availability of AEDs in public locations, and continued development of cardiovascular care infrastructure support market growth.
The Asia Pacific defibrillator market accounted for 22.8% of the global market, reaching USD 3.46 billion in 2025, and is projected to grow at a CAGR of 8.91% during the forecast period. The region records the fastest growth among the listed markets, driven by rising cardiovascular disease incidence, expanding healthcare infrastructure, increasing healthcare expenditure, greater awareness of sudden cardiac arrest, and growing adoption of advanced emergency medical technologies.
China represents a major market within the Asia Pacific. Expanding healthcare infrastructure, increasing cardiovascular disease burden, and growing investments in emergency medical equipment continue to drive demand for defibrillators.
India's expanding healthcare infrastructure, rising awareness of cardiac emergencies, increasing healthcare investments, and growing availability of emergency medical equipment continue to create opportunities for defibrillator market growth.
Japan's aging population, advanced healthcare infrastructure, high focus on cardiovascular care, and established deployment of AEDs across public and healthcare settings continue to support market development.
Latin America's defibrillator market accounted for 6.3% of the global market, reaching USD 0.96 billion in 2025, and is expected to grow at a CAGR of 6.89% during the forecast period. Increasing cardiovascular disease awareness, healthcare infrastructure development, growing emergency medical requirements, and expanding access to cardiac care technologies continue to support regional market growth.
Brazil represents a major regional market. Its large healthcare system, rising focus on cardiovascular disease management, and increasing demand for emergency medical equipment continue to create opportunities for defibrillator manufacturers.
The Middle East & Africa defibrillator market accounted for 4.9% of the global market, reaching USD 0.74 billion in 2025, and is anticipated to grow at a CAGR of 6.21% during the forecast period. Healthcare infrastructure development, increasing cardiovascular disease awareness, rising healthcare investments, and growing adoption of emergency cardiac care technologies continue to support regional market development.
The UAE's advanced healthcare infrastructure, investments in emergency medical services, and increasing focus on cardiovascular care continue to support demand for defibrillation equipment.
Saudi Arabia's expanding healthcare infrastructure, increasing investment in emergency care, and growing focus on cardiovascular disease management continue to strengthen demand for defibrillators.
The global pool tables market is highly competitive, with leading billiards equipment manufacturers competing through premium craftsmanship, innovative table designs, high-quality playing surfaces, customizable finishes, and products tailored to residential, commercial, hospitality, and professional applications. The major players in the market include American Heritage Billiards, Predator Group, Imperial International, Blatt Billiards, Brunswick Billiards, Gabriels Billiards, Legacy Billiards, Olhausen Billiard Mfg. Inc., Riley England, Valley Dynamo Inc., Garlando, Alcocks, Hathaway, Plank and Hide, Liberty Games, and others.
Industry participants are focusing on developing durable and aesthetically appealing pool tables with improved slate construction, precision leveling systems, advanced cushion technology, customizable finishes, and space-efficient designs. Companies are investing in premium materials, modern table aesthetics, convertible dining and game tables, compact models, and customized solutions for homes, clubs, hotels, entertainment venues, and professional tournaments. Growing consumer interest in recreational activities, home entertainment, luxury game rooms, and competitive billiards is also encouraging manufacturers to broaden their product portfolios and strengthen retail and online distribution channels.
Brunswick Billiards is one of the established names in the global billiards industry, offering a broad range of pool tables designed for residential, commercial, and recreational environments. The company is recognized for its traditional craftsmanship, premium materials, precision engineering, and diverse designs that combine playing performance with furniture-style aesthetics.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Tampon Market Size, Share, Growth, Opportunities, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
Vaginal Rejuvenation Market Size, Share, Growth, Analysis, 2034
Brachytherapy Market Size, Share, Growth, Analysis, Report, 2034
Nasal Drug Delivery Technology Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com